| Literature DB >> 26761850 |
Go Eun Ha1, Oun Ki Chang2, Gi Sung Han3, Jun Sang Ham3, Beom-Young Park3, Seok-Geun Jeong3.
Abstract
Milk proteins have many potential sequences within their primary structure, each with a specific biological activity. In this study, we compared and investigated the bioactivities of hydrolysates of the domestic (A, B) and imported (C, D) skim milk powders generated using papain digestion. MALDI-TOF analysis revealed that all milk powder proteins were intact, indicating no autolysis. Electrophoretic analysis of hydrolysates showed papain treatment caused degradation of milk proteins into peptides of various size. The antioxidant activity of the hydrolysates, determined using 2,2-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and total phenolic contents (TPC) assays, increased with incubation times. In all skim milk powders, the antioxidant activities of hydrolysates were highest following 24 h papain treatment (TPC: A, 196.48 μM GE/L; B, 194.52 μM GE/L; C, 194.76 μM GE/L; D, 163.75 μM GE/L; ABTS: A, 75%; B, 72%; C, 72%; D, 57%). The number of peptide derived from skim milk powders, as determined by LC-MS/MS, was 308 for A, 283 for B, 208 for C, and 135 for D. Hydrolysate A had the highest antioxidant activity and the most potential antioxidant peptides amongst the four skim milk powder hydrolysates. A total of 4 β-lactoglobulin, 4 αs1-casein, and 56 β-casein peptide fragments were identified as potential antioxidant peptides in hydrolysate A by LC-MS/MS. These results suggest that domestic skim milk could have applications in various industries, i.e., in the development of functional foods.Entities:
Keywords: antioxidant activity; antioxidant peptides; hydrolysis; papain; skim milk powder
Year: 2015 PMID: 26761850 PMCID: PMC4662359 DOI: 10.5851/kosfa.2015.35.3.360
Source DB: PubMed Journal: Korean J Food Sci Anim Resour ISSN: 1225-8563 Impact factor: 2.622
Fig. 1.MALDI-TOF analysis of skim milk powders from four different sources. A and B: domestic skim milk powders; C and D: imported skim milk powders.
Fig. 2.Electrophoresis of various skim milk powders treated with papain. Lane M: Protein standard marker; 0, 1, 2, 4, 6, 24: incubation time (h). A and B: domestic skim milk powders; C and D: imported skim milk powders.
Antioxidant activities using TPC assay of milk powder hydrolysates after papain treatment
| Skim milk powders | Incubation time (h) | |||||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 4 | 6 | 24 | |
| A | 46.38±5.21)cA | 106.65±7.6bA | 171.85±4.0aA | 183.72±2.7aA | 185.45±3.2aA | 196.48±5.6aA |
| B | 71.45±7.0cA | 88.78±0.9cbA | 112.52±2.4bB | 160.78±3.1aB | 177.98±1.0aA | 194.52±5.0aA |
| C | 37.72±3.7cA | 61.98±0.8cbB | 81.45±2.9bB | 159.18±1.1aB | 170.52±9.3aA | 194.76±7.4aA |
| D | 49.58±1.1dA | 52.50±0.2dB | 62.62±0.8cB | 85.05±1.2bC | 134.92±1.4aB | 163.75±1.4aB |
A and B: domestic skim milk powders; C and D: imported skim milk powders.
1)Means±SD (n=3).
a-dSuperscripts in rows that do not share the same letter differ (p<0.05).
A-DSuperscripts in columns that do not share the same letter differ (p<0.05).
Antioxidant activities using ABTS assay of milk powder hydrolysates after papain treatment
| Skim milk powders | Incubation time (h) | |||||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 4 | 6 | 24 | |
| A | 39.38±1.11)cA | 60.95±0.2bA | 73.66±0.3aA | 74.81±0.2aA | 72.85±0.1aA | 75.33±0.8aA |
| B | 34.23±0.1dB | 50.38±0.4cB | 57.61±0.7bB | 72.76±0.6aBA | 71.85±1.2aA | 72.09±0.2aB |
| C | 30.81±0.3eC | 42.81±0.4dC | 50.90±0.4cC | 70.95±0.4bB | 73.81±0.1aA | 72.04±0.2aB |
| D | 28.47±0.1dC | 29.38±0.0dcD | 30.28±0.3cD | 39.33±0.5bC | 43.52±0.2aB | 57.43±0.2aC |
A and B: domestic skim milk powders; C and D : imported skim milk powders.
1) Means±SD (n=3).
a-dSuperscripts in rows that do not share the same letter differ (p<0.05).
A-DSuperscripts in columns that do not share the same letter differ (p<0.05).
Antioxidant peptides identified from hydrolysates of milk protein in the literature
| Sequences | Identification of peptides from milk powder in present study | References reported | ||||
|---|---|---|---|---|---|---|
| A | B | C | D | |||
| β-CN | f98-105, VKEAMAPK | GVSKVKEAMAPK, GVSKVKEAMAPKHK, GVSKVKEAMAPKHKEMPFPK | GVSKVKEAMAPK, LQPEVMGVSKVKEAMAPK, VKEAMAPKHKEMPFPK, VMGVSKVKEAMAPK, VSKVKEAMAPK | N.D1 | GVSKVKEAMAPK, GVSKVKEAMAPKH, GVSKVKEAMAPKHK, GVSKVKEAMAPKHKE, GVSKVKEAMAPKHKEMPFPK, GVSKVKEAMAPKHKEMPFPKYPVEPFT, KVKEAMAPK, KVKEAMAPKHK, KVKEAMAPKHKEMPFPK, QPEVMGVSKVKEAMAPK, QVKEAMAPKHKEMPFPK, SKVKEAMAPKHKEMPFPK, VKEAMAPKHKEMPFPK, VSKVKEAMAPKHK, VSKVKEAMAPKHKEMPFPK | |
| Rival | ||||||
| f184-190, VLPVPQ | HQPHQPLPPTVMFPPQSVLSLSQSKVLPVPQK, QSKVLPVPQK, HQPHQPLPPTVMFPPQSVLSLSQSKVLPVPQKAVPYPQR, LSQSKVLPVPQK, MHQPHQPLPPTVMFPPQSVLSLSQSKVLPVPQK, SLSQSKVLPVPQK, SLSQSKVLPVPQKAVPYPQ, SLSQSKVLPVPQKAVPYPQR, SLSQSKVLPVPQKAVPYPQRDMP, SLSQSKVLPVPQKAVPYPQRDMPI, SLSQSKVLPVPQKAVPYPQRDMPIQAF, SLSQSKVLPVPQKAVPYPQRDMPIQAFL, SQSKVLPVPQKAVPYPQ, SQSKVLPVPQKAVPYPQR, SQSKVLPVPQKAVPYPQRDMPIQ, SQSKVLPVPQKAVPYPQRDMPIQA, VLPVPQKAVPYPQR, VLPVPQKAVPYPQRDMPI, VLPVPQKAVPYPQRDMPIQA, VLPVPQKAVPYPQRDMPIQAF, VLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPVRGPFPIIV, VLSLSQSKVLPVPQK, VLSLSQSKVLPVPQKAVPYPQ, VLSLSQSKVLPVPQKAVPYPQR, VLSLSQSKVLPVPQKAVPYPQRDMPIQA | LSQSKVLPVPQK, LSQSKVLPVPQKAVPYPQRDMPIQAF, SLSQSKVLPVPQKAVPYPQR, SLSQSKVLPVPQKAVPYPQRDMPIQA, SQSKVLPVPQKAVPYPQ, QSKVLPVPQK, SKVLPVPQK, VLPVPQKAVPYPQRD, VLPVPQKAVPYPQRDMPIQAF | LSLSQSKVLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPV, LSQSKVLPVPQK, LSQSKVLPVPQKAVPYPQR, LSQSKVLPVPQKAVPYPQRDMP, LSQSKVLPVPQKAVPYPQRDMPIQAF, LSQSKVLPVPQKAVPYPQRDMPIQAFL, MHQPHQPLPPTVMFPPQSVLSLSQSKVLPVPQK, QSKVLPVPQKAVPYPQ, SLSQSKVLPVPQK, SLSQSKVLPVPQKAVPYPQRDMPIQA, SQSKVLPVPQKAVPYPQ, VLPVPQKAVPYPQR, VLPVPQKAVPYPQRDMPIQAF, VLSLSQSKVLPVPQK, VLSLSQSKVLPVPQKAVPYPQRDMP | PQSVLSLSQSKVLPVPQK, QSKVLPVPQKAVPYPQRDMPIQAFL, SLSQSKVLPVPQK, SQSKVLPVPQK, SQSKVLPVPQKAVPYPQRDMPIQAFL | Rival | |
| f177-183, AVPYPQR | AVPYPQRDMPIQ, HQPHQPLPPTVMFPPQSVLSLSQSKVLPVPQKAVPYPQR, KAVPYPQRDMPIQAFLLYQEPVLGPVRGPFPIIV, SLSQSKVLPVPQKAVPYPQR, SLSQSKVLPVPQKAVPYPQRDMP, SLSQSKVLPVPQKAVPYPQRDMPI, SLSQSKVLPVPQKAVPYPQRDMPIQAF, SLSQSKVLPVPQKAVPYPQRDMPIQAFL, SQSKVLPVPQKAVPYPQR, SQSKVLPVPQKAVPYPQRDMPIQ, SQSKVLPVPQKAVPYPQRDMPIQA, VLPVPQKAVPYPQR, VLPVPQKAVPYPQRDMPI, VLPVPQKAVPYPQRDMPIQA, VLPVPQKAVPYPQRDMPIQAF, VLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPVRGPFPIIV, VLSLSQSKVLPVPQKAVPYPQR, VLSLSQSKVLPVPQKAVPYPQRDMPIQA | AVPYPQRDMPIQAFL, KAVPYPQRDMP, LYQEPVLGPVRGPFPI, LPVPQKAVPYPQRDMPIQ, LSQSKVLPVPQKAVPYPQRDMPIQAF, SKVLPVPQKAVPYPQRDMPIQ, SLSQSKVLPVPQKAVPYPQR, SLSQSKVLPVPQKAVPYPQRDMPIQA, TVMFPPQSVLSLSQSKVLPVPQKAVPYPQRDMPIQ, QSKVLPVPQKAVPYPQRDMPIQA, VLPVPQKAVPYPQR, VLPVPQKAVPYPQRD, VLSLSQSKVLPVPQKAVPYPQRDMP | LSLSQSKVLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPV, LSQSKVLPVPQKAVPYPQR, LSQSKVLPVPQKAVPYPQRDMP, LSQSKVLPVPQKAVPYPQRDMPIQAF, LSQSKVLPVPQKAVPYPQRDMPIQAFL, SLSQSKVLPVPQKAVPYPQRDMPIQA, VLPVPQKAVPYPQR, VLPVPQKAVPYPQRDMPIQAF, VLSLSQSKVLPVPQKAVPYPQRDMP | AVPYPQRDMPIQAFLLYEQPVLGPVR, KAVPYPQRDMPIQAFL, QSKVLPVPQKAVPYPQRDMPIQAFL, SQSKVLPVPQKAVPYPQRDMPIQAFL | Rival | |
| αs1-CN | f144-149, YFYPEL | N.D | N.D | IHAQQKEPMIGVNQELAYFYPELFRQ, LAYFYPELFRQ | EPMIGVNQELAYFYPELFR, GIHAQQKEPMIGVNQELAYFYPELFR, IGVNQELAYFYPELFR, PMIGVNQELAYFYPELFR, QKEPMIGVNQELAYFYPELFR, QQKEPMIGVNQELAYFYPELFR, VNQELAYFYPELFRQF, VNQELAYFYPELFRQFY, YFYPELFRQFYQ | |
| αs2-CN | f202-207, PYVRYL | KVIPYVRYL, TKVIPYVRYL, QKAMKPWIQPKTKVIPYVRYL | PKTKVIPYVRYL, PWIQPKTKVIPYVRYL, PMIGVNQELAYFYPELFRQFY, QKAMKPWIQPKTKVIPYVRYL, TVYQHQKAMKPWIQPKTKVIPYVRYL | KPWIQPKTKVIPYVRYL | N.D | |
| β-lg | f146-150, MHIRL | ALPMHIRLSFNPTQLEEQCHI, HIRLSFNPTQLEEQCHI | ALPMHIRLSFNPTQLEEQCHI | N.D | ALPMHIRLSFNPTQ | |
| f75-82, KTKIPAVF | IIAEKTKIPAVF, IIAEKTKIPAVFK | IIAEKTKIPAVF | IIAEKTKIPAVF, IIAEKTKIPAVFK | N.D | ||
| The number of total peptides | 53 | 33 | 32 | 34 | ||
1N.D = not detected.